Product Information
BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Bausch & Lomb Incorporated, priced at $10.3303 per ML under NDC 24208046415. Its NADAC has been published 34 times since Nov 5, 2025.
Strength
10 mg/mL
Manufacturer
Bausch & Lomb IncorporatedNDC
24208046415
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
BRINZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204884On Market Since
3/31/2022
Pharmacological Classes
Price Statistics
The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 34 times since Nov 5, 2025, and over the history we have for it it has declined 16.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3303 per ML |
|---|---|
| All-time high | $14.3013 (Feb 11, 2026) |
| All-time low | $10.0825 (Apr 22, 2026) |
| 52-week high | $14.3013 |
| 52-week low | $10.0825 |
| Median price | $12.3315 |
| Average price | $11.8672 |
| Largest weekly change | +14.5% (Jan 21, 2026) |
| Weeks tracked | 34 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Bausch & Lomb Incorporated, is $10.3303 per ML (NDC 24208046415), effective Jun 24, 2026.
How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 16.8%. It has been tracked across 34 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?
Since Nov 5, 2025, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $10.0825 (Apr 22, 2026) to a high of $14.3013 (Feb 11, 2026), with a median of $12.3315 per ML.
Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BRINZOLAMIDE 1% EYE DROPS, is $10.0197 per ML — about 3% below BRINZOLAMIDE 1% EYE DROPS.
Who manufactures BRINZOLAMIDE 1% EYE DROPS?
BRINZOLAMIDE 1% EYE DROPS (NDC 24208046415) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.
Related Drugs
Same classification